Related Experiment Video
Updated: Aug 23, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study
Jiazheng Chen1, Hongli Li2, Yuxin Liang2
1School of the Fifth Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Insights
Lower circulating Caveolin-1 (Cav-1) levels are linked to increased coronary artery disease (CAD) risk in Chinese adults. Measuring Cav-1 may help refine CAD risk stratification beyond conventional factors.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Molecular Biology
Background:
- Coronary artery disease (CAD) is a leading global cause of mortality, with a significant portion of risk unexplained by traditional factors.
- Caveolin-1 (Cav-1) plays a role in endothelial function and its genetic variants are associated with CAD risk.
- The clinical utility of circulating Cav-1 as a biomarker for CAD risk stratification is currently unknown.
Purpose of the Study:
- To investigate the association between circulating Caveolin-1 (Cav-1) levels and the risk of coronary artery disease (CAD).
- To evaluate the potential of Cav-1 as a clinical biomarker for CAD risk stratification.
Main Methods:
- Retrospective cohort study of 160 participants (105 CAD patients, 55 controls) undergoing coronary angiography.
- Serum Cav-1 levels measured via ELISA; CAD defined as ≥50% stenosis in major coronary arteries.
- Multivariable logistic regression, restricted cubic spline (RCS), and receiver operating characteristic (ROC) curve analyses were employed.
Main Results:
- CAD patients had significantly lower serum Cav-1 levels compared to controls (7.0 ± 2.7 vs. 8.5 ± 2.7 ng/mL, P=0.001).
- Each 1 ng/mL increase in Cav-1 was associated with an 18% reduction in CAD risk (OR 0.82, P=0.031), showing a consistent linear inverse relationship.
- Combining Cav-1 with albumin significantly improved discriminative performance (AUC 88.4%), approaching the full multivariable model.
Conclusions:
- Circulating Cav-1 is independently and inversely associated with CAD risk in Chinese adults.
- Cav-1 demonstrates potential as a novel biomarker for refining CAD risk stratification.
- The combination of Cav-1 and albumin shows robust discriminative capability for CAD.
Background:
Coronary artery disease (CAD) remains a leading cause of mortality globally, yet approximately 30% of CAD risk remains unexplained by conventional factors. Caveolin-1 (Cav-1) regulates endothelial function through inhibiting endothelial nitric oxide synthase and promoting LDL transcytosis. While genome-wide association studies linked CAV1 variants to CAD risk (OR 1.19-1.23), whether circulating Cav-1 serves as a clinical biomarker for CAD risk stratification remains unknown.
Methods:
This retrospective cohort study enrolled 160 participants (105 CAD patients, 55 controls) who underwent coronary angiography at Shanxi Provincial People's Hospital, China, from September 2024 to February 2025. CAD was defined as ≥50% stenosis in major coronary arteries. Serum Cav-1 levels were measured using ELISA. Multivariable logistic regression models adjusted for age, sex, lipids, and biomarkers evaluated Cav-1's independent association with CAD. Restricted cubic spline (RCS) analysis assessed dose-response relationships, and receiver operating characteristic (ROC) curves evaluated discriminative performance.
Results:
CAD patients exhibited significantly lower Cav-1 levels than controls (7.0 ± 2.7 vs. 8.5 ± 2.7 ng/mL, P = 0.001). After full adjustment, each 1 ng/mL increase in Cav-1 conferred 18% CAD risk reduction (OR 0.82, 95% CI 0.68-0.98, P = 0.031). Participants in the highest Cav-1 quartile demonstrated 80% lower risk vs. the lowest quartile (OR 0.20, 95% CI 0.05-0.84, P = 0.028; P for trend <0.01). RCS analysis revealed a consistent linear inverse relationship (P for nonlinearity = 0.812). Combining Cav-1 with albumin significantly enhanced discrimination (AUC 88.4%, 95% CI 83.3-93.5), approaching the full multivariable model performance (AUC 89.8%).
Conclusions:
Circulating Cav-1 demonstrates an independent, linear inverse association with CAD risk in Chinese adults. Combined with albumin, Cav-1 achieves robust discriminative performance, suggesting potential utility for refined risk stratification beyond traditional risk factors.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies